Home » Authors » Nuala Moran

Articles by Nuala Moran

MMI Group Pushes Ahead With Work In Ruthenium Compounds

Sep. 24, 2003

Alizyme Reports Strong Phase II Results On Drug For Weight Loss

Sep. 24, 2003

Alizyme Reports Strong Phase II Results On Drug For Weight Loss

Sep. 24, 2003

Genzyme Invests $37.7M In CAT As Companies Restructure Pact

Sep. 24, 2003

MMI Group Pushes Ahead With Work In Ruthenium Compounds

Sep. 24, 2003

Genzyme Invests $37.7M In CAT As Companies Restructure Pact

Sep. 23, 2003

Genzyme Invests $37.7M In CAT As Companies Restructure Pact

Sep. 23, 2003

Oxford BioMedica Raises £22.1M To Fund 7 Development Programs

Sep. 17, 2003

PPL Puts Itself On The Block, Leaves Legacy Of Cloned Dolly

Sep. 17, 2003

Xention Raises £4M In Second Round For Work In Ion Channels

Sep. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...